A new study examining the effects of omega-3 supplements on the cognitive health of older adults revealed that their consumption could be related to accelerated mental deterioration. This contradicts the judgments in their favor that they have garnered for time, which place these supplements on the pedestal of health benefits for the human being.

The research, published in Journal of Prevention of Alzheimer's Disease, which spanned five years, analyzed 273 older adults who took omega-3 and 546 who did not do so, matching the groups by age and clinical profile to obtain valid results.

Subjects were evaluated with standard tools, such as MMSE and CDR-SB, revealing that those who consumed omega-3 showed a more rapid decline in their cognitive abilities.

Genetic and neurological factors

Despite the alarming observations, the study revealed that the differences in cognitive impairment are not explained by traditional Alzheimer's factors, such as the presence of the APOE ε4 gene.

Brain imaging indicated a decrease in glucose metabolism among omega-3 users, which could be related to dysfunction in neural communication.

Implications and recommendations

The researchers emphasize that these findings are not definitive and that the study does not establish causality. They advise consultation with healthcare professionals before initiating any supplementation.

The results urge a reevaluation of the use of omega-3 supplements in older adults, questioning their efficacy as a prevention strategy for cognitive deterioration.

How to address contradictions about supplements?

Health professionals should prioritize scientific evidence and clear communication to guide patients in the face of conflicting information about supplements.

Evaluate evidence. Check reliable sources such as clinical studies in indexed journals and guidelines from agencies such as the Food and Drug Administration (FDA) or the Institute. National Health Utos (NIH), dismissing unsupported marketing claims. Recommend supplements only if there are deficiencies confirmed by evidence, avoiding generalizations.

Discuss risks. Explain possible interactions with medications, contaminants such as heavy metals or common adulterations (e.g. sibutramine in weight loss products). Consider contraindications in patients with pre-existing conditions, such as hypertension or cancer.

Encourage dialogue. Ask about all supplements the patient takes and use updated lists to review at appointments; suggest ce marks rtified and periodic monitoring. Promote a balanced diet as a base, clarifying that supplements do not replace proven treatments.

Use tools. Use clinical databases to check interactions and educate about lax regulations that allow products not regulated as “natural” but risky. Document advice to empower informed decisions and report adverse effects.

You might also be interested:

First non-antipsychotic drug approved for agitation in Alzheimer's disease Researchers can achieve early detection of Alzheimer's through voice With records from almost 28 million Americans, reveal what could be the direct cause of Alzheimer's